ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,342,000 | -19.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,891,000 | -9.6% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,199,000 | -49.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,278,000 | -45.1% | 11,206 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $11,430,000 | -25.0% | 11,206 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $15,240,000 | -20.0% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $19,050,000 | +37.1% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $13,895,000 | -12.7% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,913,000 | +17.4% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $13,559,000 | +17.5% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,542,000 | -39.1% | 11,206 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $18,938,000 | – | 11,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |